Can neurodegenerative disease disrupt sleep-wake regulation and make sleep fragmentation worse for attention and memory?

Neurodegenerative illness—most clearly Alzheimer’s disease—is associated with disturbed sleep continuity and altered sleep–wake rhythms. In a 74-year-old, these changes can coexist with, and potentially compound, cognitive symptoms, but they should not automatically be attributed to neurodegeneration alone.

Clinical evidence

• A systematic review/meta-analysis of 28 studies in Alzheimer’s disease found reduced total sleep time, sleep efficiency, slow-wave sleep, and REM sleep, alongside more wake after sleep onset and awakenings. Reduced slow-wave and REM sleep correlated with worse cognitive impairment.
• Sleep fragmentation has a particularly consistent relationship with memory: meta-analytic evidence links poorer continuity, especially greater wake after sleep onset, to poorer episodic memory, with stronger associations in older adults.
• Attention effects are plausible but less certain. In MCI and cohorts of older women, longer wake after sleep onset was associated with poorer attention and executive/problem-solving performance; experimental fragmentation altered attention-related EEG measures but did not consistently impair behavioral attention testing.
• Prospective actigraphy studies associate greater fragmentation with faster cognitive decline and higher incident Alzheimer’s disease risk, although these associations do not prove that fragmentation causes decline or disease.

Mechanistic and practical context

• Dysfunction or degeneration in brainstem and hypothalamic sleep–wake regulatory systems is a biologically plausible contributor to fragmented sleep, altered architecture, and daytime sleepiness in Alzheimer’s-spectrum disease.
• The relationship is likely bidirectional: neurodegeneration may disrupt sleep, while fragmented sleep may be linked to worse memory and longitudinal cognitive outcomes.
• Other treatable contributors remain important, including sleep apnea, medications, pain, mood symptoms, medical illness, and environmental disruption. Sleep history, caregiver observations, diary/actigraphy, and polysomnography when indicated can help distinguish these.

Bottom line

• Neurodegenerative disease can disrupt sleep–wake regulation, and fragmented sleep is strongly linked with poorer memory and plausibly poorer attention. Addressing identifiable causes of fragmented sleep is clinically reasonable, while recognizing that evidence for direct cognitive improvement from treating fragmentation remains incomplete.